Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesis
摘要:
Peroxisome proliferator-activated receptor gamma (PPAR gamma) antagonists are candidates for treatment of type 2 diabetes, obesity and osteoporosis. However, few rational design strategies are currently available. Here, we utilized the helix12 (H12)-folding inhibition hypothesis, in combination with our previously determined X-ray crystal structure of PPAR gamma agonist MEKT-21 (6) complexed with the PPAR gamma ligand-binding domain, to design and develop a potent phenylalkynyl amide-type PPAR gamma antagonist 9i, focusing initially on pinpoint structural modification of the propanoic acid moiety of 6. Since 9i retained very weak, but distinct, PPAR gamma agonist activity, we next modified the distal benzene ring of 9i, aiming to delete the residual PPAR gamma agonist activity while retaining the antagonist activity. Introduction of a chlorine atom at the 2-position of the distal benzene ring afforded 9p, which exhibited potent, PPAR gamma-selective full antagonist activity without detectable agonist activity. We found that 9p stabilized the corepressor PPAR gamma complex and suppressed basal PPAR gamma activity. This compound showed anti-adipogenesis activity at the cellular level. This agonist antagonist switching concept based on the H12-folding inhibition hypothesis should also be applicable for designing other classes of PPAR gamma full antagonists. (C) 2014 Elsevier Masson SAS. All rights reserved.
Highly Efficient Copper-Catalyzed Synthesis of Internal Alkynes<i>via</i>Aerobic Oxidative Arylation of Terminal Alkynes
作者:Honghua Rao、Hua Fu、Yuyang Jiang、Yufen Zhao
DOI:10.1002/adsc.200900723
日期:2010.2.15
We have developed a novel and highlyefficient, copper-catalyzed synthesis of internal alkynes via oxidative couplings of aromatic boronic acids with terminalalkynes at room temperature. The protocol uses inexpensive copper(I) oxide [Cu2O] as the catalyst, oxygen in the air as the stoichiometric oxidant; no ligand and sealed reaction vessels are required, and remarkable functional group tolerability
Borane-catalyzed cascade Friedel–Crafts alkylation/[1,5]-hydride transfer/Mannich cyclization to afford tetrahydroquinolines
作者:Bei-Bei Zhang、Shuo Peng、Feiyi Wang、Cuifen Lu、Junqi Nie、Zuxing Chen、Guichun Yang、Chao Ma
DOI:10.1039/d1sc05629h
日期:——
An unprecedented redox-neutral annulation reaction of tertiary anilines with electron-deficient alkynes was developed that proceeds through a cascade Friedel–Crafts alkylation/[1,5]-hydride transfer/Mannich cyclization sequence. Under B(C6F5)3 catalysis, a range of functionalized 1,2,3,4-tetrahydroquinolines were facilely constructed in moderate to good yields with exclusive 3,4-anti-stereochemistry
A novel palladium-catalyzed, one-pot, four-step cascademethod has been developed to afford functionalized gamma-lactones in moderate to good yields. This novel and general methodology represents a rare instance of carbonylation of the C(sp(3))-palladium bond.
A simple and efficient synthesis of cyclopentadienones via palladium-catalyzed cyclocarbonylation of alkynes under atmosphericpressure of carbonmonoxide has been developed. The transformation was carried out under mild and ligand-free conditions, a wide range of substrates and exceptional functional group tolerance.
Rh/bisphosphine−thiourea ligand (ZhaoPhos)‐catalyzed asymmetric hydrogenation of (Z)‐β‐substituted‐β‐boryl‐α,β‐unsaturatedesters was successfully developed, furnishing a variety of chiral β‐borylated carboxylic esters with high yields and excellent enantioselectivities (up to 99% yield and >99% ee). The gram‐scale asymmetric hydrogenation was performed efficiently in the presence of only 0.05 mol%
成功开发了Rh /双膦-硫脲配体(ZhaoPhos)催化的(Z)-β-取代的-β-硼基-α,β-不饱和酯的不对称加氢反应,提供了高收率的多种手性β-硼化羧酸酯优异的对映选择性(高达99%的收率和> 99%的ee)。在仅0.05 mol%(S / C = 2 000)催化剂负载的情况下,可以有效地进行克级不对称氢化反应,并具有完全转化率,99%的收率和99%的ee。此外,加氢产物很容易转化为其他通用的合成中间体,例如(S)-3-羟基-3-苯基丙酸甲酯和(S)-3-(呋喃-2-基)-3-苯基丙酸甲酯。